Search Immortality Topics:



Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD’s anti-PD-1 therapy…

Posted: November 22, 2020 at 1:59 pm

See the original post here:
Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD’s anti-PD-1 therapy...

Recommendation and review posted by Fredricko